| SARS-CoV-2-specific memory T lymphocytes from COVID-19 convalescent donors: identification, biobanking, and large-scale production for adoptive cell therapy C Ferreras, B Pascual-Miguel, C Mestre-Duran, A Navarro-Zapata, ... Frontiers in cell and developmental biology 9, 620730, 2021 | 46 | 2021 |
| Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE) A Pérez-Martínez, M Mora-Rillo, C Ferreras, P Guerra-García, ... EClinicalMedicine 39, 2021 | 28 | 2021 |
| Ruxolitinib for steroid-refractory graft versus host disease in pediatric HSCT: high response rate and manageable toxicity Y Mozo, D Bueno, L Sisinni, A Fernández-Arroyo, B Rosich, AP Martínez, ... Pediatric Hematology and Oncology 38 (4), 331-345, 2021 | 21 | 2021 |
| Anti-CXCR4 antibody combined with activated and expanded natural killer cells for sarcoma immunotherapy M Vela, D Bueno, P González-Navarro, A Brito, L Fernández, A Escudero, ... Frontiers in Immunology 10, 1814, 2019 | 20 | 2019 |
| Optimizing the procedure to manufacture clinical-grade NK cells for adoptive immunotherapy A Fernández, A Navarro-Zapata, A Escudero, N Matamala, ... Cancers 13 (3), 577, 2021 | 19 | 2021 |
| Phase 2 clinical trial of infusing haploidentical K562-mb15-41BBL–activated and expanded natural killer cells as consolidation therapy for pediatric acute myeloblastic leukemia LMG García, A Escudero, C Mestre, JLF Soler, AP Martínez, JMV Valero, ... Clinical Lymphoma Myeloma and Leukemia 21 (5), 328-337. e1, 2021 | 9 | 2021 |
| Familial CD45RA–T cells to treat severe refractory infections in immunocompromised patients K Al-Akioui Sanz, C Echecopar Parente, C Ferreras, M Menéndez Ribes, ... Frontiers in Medicine 10, 1083215, 2023 | 4 | 2023 |
| Donor’s graft ex vivo T‐cell depletion with fludarabine reduces graft‐versus‐host disease signs and improves survival after intestinal transplantation – an … M Vela, P Stringa, P González‐Navarro, M Machuca, B Pascual‐Miguel, ... Transplant International 33 (10), 1302-1311, 2020 | 4 | 2020 |
| Donor selection for adoptive cell therapy with CD45RA− memory T cells for patients with coronavirus disease 2019, and dexamethasone and interleukin-15 effects on the phenotype … K Al-Akioui-Sanz, B Pascual-Miguel, M Díaz-Almirón, C Mestre-Durán, ... Cytotherapy 25 (3), 330-340, 2023 | 3 | 2023 |
| Haploidentical hematopoietic stem cell transplantation in pediatric and adolescent patients: A study of the Spanish hematopoietic stem cell transplantation group (GETH) B Ochoa-Fernández, V Galán-Gómez, C Mestre, M González-Vicent, ... Medicina Clínica (English Edition) 159 (9), 411-419, 2022 | 3 | 2022 |
| NKG2D-CAR memory T cells target pediatric T-cell acute lymphoblastic leukemia in vitro and in vivo but fail to eliminate leukemia initiating cells M Ibáñez-Navarro, A Fernández, A Escudero, G Esteso, C Campos-Silva, ... Frontiers in Immunology 14, 1187665, 2023 | 2 | 2023 |
| Ruxolitinib does not completely abrogate the functional capabilities of TLR4/9 ligand-activated NK cells C Mestre-Durán, C Martín-Cortázar, B García-Solís, A Pernas, L Pertíñez, ... Frontiers in Immunology 13, 1045316, 2023 | 2 | 2023 |
| Trasplante de progenitores hematopoyéticos de donante haploidéntico en pacientes pediátricos y adolescentes: un estudio del Grupo Español de Trasplante Hematopoyético (GETH) B Ochoa-Fernández, V Galán-Gómez, C Mestre, M González-Vicent, ... Medicina Clínica 159 (9), 411-419, 2022 | | 2022 |
